2nd Quarter - Report
OGR for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Firm
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General prescription drug affordability and access.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MICHAEL DEE BUCHANAN New | Chief of Staff, House Republican Conference; Chief of Staff/ Dep. Chief of Staff/ Legislative Director, Rep. Jeb Hensarling; Dir, Sen. Phil Gramm |
| CHRIS GIBLIN New | Chief of Staff, Rep. John Carter; Legislative Director, Rep. Charlie Norwood |
| TIMOTHY MCGIVERN New | Chief of Staff, Senator Sam Brownback |
| KARISSA WILLHITE | — |
Medicare/Medicaid MMM
Provisions related to Part D access and drug pricing negotiation. Compulsory licensing policy issues. H.R.1046, Medicare Negotiation and Competitive Licensing Act of 2019. Proposed HHS Rule on Rebates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MICHAEL DEE BUCHANAN New | Chief of Staff, House Republican Conference; Chief of Staff/ Dep. Chief of Staff/ Legislative Director, Rep. Jeb Hensarling; Dir, Sen. Phil Gramm |
| CHRIS GIBLIN New | Chief of Staff, Rep. John Carter; Legislative Director, Rep. Charlie Norwood |
| TIMOTHY MCGIVERN New | Chief of Staff, Senator Sam Brownback |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.